As of 2025-11-17, the Fair Value of VIMAB Group AB (publ) (VIMAB.ST) is -12.01 SEK. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 3.93 SEK, the upside of VIMAB Group AB (publ) is -405.61%.
With the market price of 3.93 SEK and our fair value calculation, VIMAB Group AB (publ) (VIMAB.ST) is not a good investment. Investing in VIMAB.ST stocks now will result in a potential loss of 405.61%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -28.40 | 131.20 | -34.22 | -4.26 | -76.94 | -2.52 |
| YoY growth | -1,192.31% | 561.97% | -126.08% | 87.55% | -1,706.55% | -475.08% |
| Market Cap (mil) | 148.65 |
| P/E | |
| Forward P/E |
| EPS | -2.40 |
| Avg earnings growth rate | -475.08% |
| TTM earnings | -90.86 |